WELL Health Technologies Corp. WELL.TO
TSX
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 7.77% | -2.73% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 7.77% | -2.73% | |||
| Cost of Revenue | 7.29% | 0.25% | |||
| Gross Profit | 8.37% | -6.24% | |||
| SG&A Expenses | 9.73% | -9.95% | |||
| Depreciation & Amortization | 7.25% | 16.53% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.11% | -2.48% | |||
| Operating Income | 1.69% | -6.95% | |||
| Income Before Tax | 101.34% | -137.08% | |||
| Income Tax Expenses | 636.52% | 88.97% | |||
| Earnings from Continuing Operations | -44.93% | -116.92% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 56.15% | 21.30% | |||
| Net Income | 12.66% | -154.98% | |||
| EBIT | 1.69% | -6.95% | |||
| EBITDA | 4.83% | 98.41% | |||
| EPS Basic | 12.71% | -155.14% | |||
| Normalized Basic EPS | 26.11% | -38.10% | |||
| EPS Diluted | 15.11% | -157.32% | |||
| Normalized Diluted EPS | 26.11% | -38.10% | |||
| Average Basic Shares Outstanding | 0.22% | -0.37% | |||
| Average Diluted Shares Outstanding | 0.22% | -0.37% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||